Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Rides To Solid First Quarter On Diabetes, Newer Products

Apr 24 2018

• By Joseph Haas

Competitive edge and business advantage concept as a group of hot air balloons racing to the top but an individualleader with a small balloon attached giving the winning competitor an extra boost.

Related Content

Novo Nordisk To Target 'New GLP-1 Patients Only' With Weekly Ozempic

Feb 25 2018

Novo Nordisk's Oral Semaglutide Succeeds In First Phase III, But Prompts Questions

Feb 23 2018

Pharma Q1 Results Preview: Lilly, Biogen, Amgen, GSK & Roche

Apr 20 2018

Lilly May Need To Reassess Baricitinib Market After FDA Advisory Committee

Apr 24 2018

Related Companies

Eli Lilly and Company

Novo Nordisk A/S

Additional Topics

Sales & Earnings Business Strategies Commercial Launches Metabolic Disorders BioPharmaceutical

More from Earnings

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window